Search clinical trials for: LY2523355

Total 7 results

Kyowa Kirin Co., Ltd.

Completed

A Study of LY2523355 in Patients With Solid Cancer (2523355-001)

Solid Tumors

Japan
Eli Lilly and Company

Completed

A Dose-Escalation Study for Patients With Advanced Cancer

Advanced Cancer

United States
Eli Lilly and Company

Terminated

A Study for Patients With Acute Leukemia

Acute Leukemia

United States
Eli Lilly and Company

Completed

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cancer of Head and Neck

United States
Eli Lilly and Company

Completed

A Study for Participants With Advanced Cancer

Metastatic Cancer | Advanced Cancer

United States
Eli Lilly and Company

Completed

A Study of LY2523355 in Participants With Breast Cancer

Metastatic Breast Cancer

United States
Eli Lilly and Company

Completed

A Study for Participants With Small-Cell Lung Cancer

Small Cell Lung Cancer

United States, Korea, Republic of, Romania

3

Subscribe